Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy.

Skaznik-Wikiel ME, McGuire MM, Sukhwani M, Donohue J, Chu T, Krivak TC, Rajkovic A, Orwig KE.

Fertil Steril. 2013 Jun;99(7):2045-54.e3. doi: 10.1016/j.fertnstert.2013.01.135. Epub 2013 Feb 26.

2.

Granulocyte colony-stimulating factor prevents loss of spermatogenesis after sterilizing busulfan chemotherapy.

Benavides-Garcia R, Joachim R, Pina NA, Mutoji KN, Reilly MA, Hermann BP.

Fertil Steril. 2015 Jan;103(1):270-80.e8. doi: 10.1016/j.fertnstert.2014.09.023. Epub 2014 Nov 5.

3.

Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model.

Akdemir A, Zeybek B, Akman L, Ergenoglu AM, Yeniel AO, Erbas O, Yavasoglu A, Terek MC, Taskiran D.

J Gynecol Oncol. 2014 Oct;25(4):328-33. doi: 10.3802/jgo.2014.25.4.328. Epub 2014 Jun 18.

4.

Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice.

Detti L, Uhlmann RA, Zhang J, Diamond MP, Saed GM, Fletcher NM, Lu M, Williams LJ.

Fertil Steril. 2014 Apr;101(4):1157-64.e1. doi: 10.1016/j.fertnstert.2013.12.028. Epub 2014 Jan 23.

PMID:
24462062
5.

Granulocyte colony-stimulating factor in conjunction with vascular endothelial growth factor maintains primordial follicle numbers in transplanted mouse ovaries.

Skaznik-Wikiel ME, Sharma RK, Selesniemi K, Lee HJ, Tilly JL, Falcone T.

Fertil Steril. 2011 Mar 15;95(4):1405-9. doi: 10.1016/j.fertnstert.2010.12.036. Epub 2011 Jan 26.

6.

Granulocyte colony-stimulating factor (G-CSF) promotes spermatogenic regeneration from surviving spermatogonia after high-dose alkylating chemotherapy.

Kotzur T, Benavides-Garcia R, Mecklenburg J, Sanchez JR, Reilly M, Hermann BP.

Reprod Biol Endocrinol. 2017 Jan 11;15(1):7. doi: 10.1186/s12958-016-0226-1.

7.

Somatic and reproductive outcomes in mice treated with cyclophosphamide in pre-pubertal age.

Detti L, Martin DC, Williams RW, Schlabritz-Loutsevich N, Williams LJ, Uhlmann RA.

Syst Biol Reprod Med. 2013 Jun;59(3):140-5. doi: 10.3109/19396368.2012.751463. Epub 2013 Jan 2.

PMID:
23278118
8.

Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist.

Ozcelik B, Turkyilmaz C, Ozgun MT, Serin IS, Batukan C, Ozdamar S, Ozturk A.

Fertil Steril. 2010 Mar 15;93(5):1609-14. doi: 10.1016/j.fertnstert.2009.02.054. Epub 2009 Apr 1.

PMID:
19339002
10.

Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L.

Hematology. 2007 Apr;12(2):141-7.

PMID:
17454195
11.

Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation.

Blumenfeld Z, Patel B, Leiba R, Zuckerman T.

Fertil Steril. 2012 Nov;98(5):1266-70.e1. doi: 10.1016/j.fertnstert.2012.07.1144. Epub 2012 Aug 27.

PMID:
22935556
12.

Questioning GnRH analogs for gonadal protection in cancer patients.

Oktay K, Sönmezer M.

Fertil Steril. 2009 Aug;92(2):e32; author reply e34. doi: 10.1016/j.fertnstert.2009.06.004. No abstract available.

PMID:
19646599
13.

Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice.

Roti Roti EC, Ringelstetter AK, Kropp J, Abbott DH, Salih SM.

PLoS One. 2014 Sep 24;9(9):e108174. doi: 10.1371/journal.pone.0108174. eCollection 2014.

14.

Randomized comparison of progenitor-cell mobilization using chemotherapy, stem-cell factor, and filgrastim or chemotherapy plus filgrastim alone in patients with ovarian cancer.

Weaver A, Chang J, Wrigley E, de Wynter E, Woll PJ, Lind M, Jenkins B, Gill C, Wilkinson PM, Pettengell R, Radford JA, Collins CD, Dexter TM, Testa NG, Crowther D.

J Clin Oncol. 1998 Aug;16(8):2601-12.

PMID:
9704709
16.

Transplantation of adipose-derived stem cells combined with collagen scaffolds restores ovarian function in a rat model of premature ovarian insufficiency.

Su J, Ding L, Cheng J, Yang J, Li X, Yan G, Sun H, Dai J, Hu Y.

Hum Reprod. 2016 May;31(5):1075-86. doi: 10.1093/humrep/dew041. Epub 2016 Mar 9.

PMID:
26965432
17.

Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?

Hasky N, Uri-Belapolsky S, Goldberg K, Miller I, Grossman H, Stemmer SM, Ben-Aharon I, Shalgi R.

Hum Reprod. 2015 May;30(5):1089-101. doi: 10.1093/humrep/dev037. Epub 2015 Mar 21.

PMID:
25796551
18.
19.
20.

Fertility after treatment for Hodgkin's disease.

Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM.

Ann Oncol. 2002;13 Suppl 1:138-47. Review.

PMID:
12078896

Supplemental Content

Support Center